each MN manufacturer and wholesaler must report every sale, delivery, and any additional distributions of controlled substances within or into the state. This reporting is referred to as Opiate Product Reporting and is an initiative to begin monitoring selected controlled substances from the point of manufacture to the point the controlled substance is dispensed to the patient. Wholesalers and manufacturers will use PMP Clearinghouse to complete Opiate Product Reporting.
Need help with ARCOS? Submit a request for support here.